Combined Intravitreal Ranibizumab and Photodynamic Therapy for Retinal Angiomatous Proliferation

Combined intravitreal ranibizumab and PDT for patients with retinal angiomatous proliferation effectively maintained or improved visual acuity and reduced the exudation without adverse events.